Highmark Health remained financially strong in 2022, reporting $26 billion in consolidated revenue, an operating gain of $440 million, and a net loss of $346 million. Excluding unrealized investment impact, the organization reported net earnings of roughly $47 million for 2022. As of December 31, 2022, the organization had $11 billion in cash and investments and net assets of $9 billion.
This strong balance sheet and steady financial performance supported excellent or stable ratings from credit agencies, including Highmark Inc.'s A+ issuer credit rating from AM Best, Standard & Poor's affirmation of an "A" financial strength rating, and Moody’s "Baa1" (or stable outlook) rating.
Highmark Health Year-End 2022 Financials